Moreover, LAG3/GAL-3 blockade can efficiently enhance the proliferation of T cells in MM patients and functional activities of MM-specific CTL, including XBP1/CD138/CS1-targeting memory CD8+ T cells, against MM. This evidence concerns the gene LAG3 and Miyoshi myopathy.